Alignment Healthcare Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Alignment Healthcare Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- ALHC
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001832466
Board of directors
-
David C. Hodgson · DirectorSince 2023
- Since 2023
-
Jeffrey H. Margolis · DirectorSince 2023
-
Jody L. Bilney · DirectorSince 2023
-
John E. Kao · Director · Chief Executive OfficerSince 2023
-
Joseph S. Konowiecki · Director · EVP, Corporate AffairsSince 2023
-
Margaret M. McCarthy · DirectorSince 2023
-
Mark B. McClellan · DirectorSince 2023
-
Nicholas Robbert Vorhoff · DirectorSince 2023
-
Thomas J. Carella · DirectorSince 2023
-
Yon Jorden · DirectorSince 2023
Chief executives
John E. Kao
· Chief Executive Officer
Dates unknown
Board connections
6 of this board's directors also sit on 13 other boards.
- via David C. Hodgson and Jacqueline B. Kosecoff
- via Margaret M. McCarthy
- via Yon Jorden
- via Yon Jorden
- via Jody L. Bilney
- via Margaret M. McCarthy
- via Jacqueline B. Kosecoff
- via Jacqueline B. Kosecoff
- via Mark B. McClellan
- via Margaret M. McCarthy
- via David C. Hodgson
- via Jacqueline B. Kosecoff
- via Mark B. McClellan
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $197,627
- 1 purchase by 1 insider
- Sold, last 12 months
- $525,425,621
- 82 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | Joseph S. Konowiecki Director, Officer (EVP, Corporate Affairs) | Open-market sale | −23,511 | $8.61 | $202,430 |
| Sep 14, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −27,400 | $13.00 | $356,200 |
| Sep 11, 2026 | Maroney Dawn Christine Officer (President) | Open-market sale | −122,707 | $12.68 | $1,555,925 |
| Sep 11, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −385,270 | $12.68 | $4,885,224 |
| Sep 10, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −172,600 | $12.96 | $2,236,447 |
| Aug 14, 2026 | Maroney Dawn Christine Officer (President) | Open-market sale | −5,000 | $14.00 | $70,000 |
| Aug 10, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −298,000 | $13.88 | $4,136,776 |
| Jul 15, 2026 | Maroney Dawn Christine Officer (President) | Option exercise | +152,068 | $9.06 | $1,377,736 |
| Jul 15, 2026 | Maroney Dawn Christine Officer (President) | Open-market sale | −177,068 | $20.83 | $3,687,990 |
| Jul 10, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −279,644 | $19.81 | $5,540,363 |
| Jul 10, 2026 | John E. Kao Director, Officer (Chief Executive Officer) | Open-market sale | −18,356 | $20.65 | $378,998 |
| Jul 1, 2026 | Joseph S. Konowiecki Director, Officer (EVP, Corporate Affairs) | Open-market sale | −25,000 | $24.00 | $600,000 |
| Jul 1, 2026 | Hochradel Shane J. Officer (Chief Operations Officer) | Grant or award | +87,719 | — | — |
| Jun 26, 2026 | Joseph S. Konowiecki Director, Officer (EVP, Corporate Affairs) | Open-market sale | −25,000 | $23.00 | $575,000 |
| Jun 18, 2026 | Joseph S. Konowiecki Director, Officer (EVP, Corporate Affairs) | Open-market sale | −25,000 | $22.00 | $550,000 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.